Banque Cantonale Vaudoise Decreases Holdings in McKesson Co. (NYSE:MCK)

Banque Cantonale Vaudoise trimmed its position in McKesson Co. (NYSE:MCKFree Report) by 13.5% during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,679 shares of the company’s stock after selling 418 shares during the quarter. Banque Cantonale Vaudoise’s holdings in McKesson were worth $1,165,000 at the end of the most recent quarter.

Other hedge funds have also recently bought and sold shares of the company. Kendall Capital Management raised its stake in shares of McKesson by 73.9% during the second quarter. Kendall Capital Management now owns 1,687 shares of the company’s stock valued at $721,000 after purchasing an additional 717 shares during the period. Aspire Private Capital LLC boosted its position in McKesson by 3.2% in the 3rd quarter. Aspire Private Capital LLC now owns 1,957 shares of the company’s stock valued at $851,000 after buying an additional 60 shares during the last quarter. Raymond James & Associates grew its stake in shares of McKesson by 0.4% during the third quarter. Raymond James & Associates now owns 144,396 shares of the company’s stock valued at $62,791,000 after acquiring an additional 533 shares in the last quarter. Brown Advisory Inc. lifted its stake in shares of McKesson by 4.8% in the second quarter. Brown Advisory Inc. now owns 3,844 shares of the company’s stock worth $1,643,000 after acquiring an additional 175 shares in the last quarter. Finally, C WorldWide Group Holding A S acquired a new stake in McKesson during the 2nd quarter valued at approximately $2,151,000. Hedge funds and other institutional investors own 82.69% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities analysts have recently commented on the company. Wells Fargo & Company started coverage on McKesson in a research note on Thursday, December 14th. They set an “equal weight” rating and a $502.00 target price for the company. UBS Group raised their price objective on McKesson from $525.00 to $559.00 and gave the stock a “buy” rating in a research note on Monday, January 29th. Mizuho upped their target price on McKesson from $427.00 to $450.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. JPMorgan Chase & Co. boosted their price objective on McKesson from $495.00 to $514.00 and gave the company an “overweight” rating in a research report on Friday, November 17th. Finally, Evercore ISI increased their target price on McKesson from $485.00 to $490.00 in a research report on Wednesday, October 11th. Two analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $495.38.

View Our Latest Stock Report on McKesson

Insiders Place Their Bets

In other news, CEO Brian S. Tyler sold 14,026 shares of the company’s stock in a transaction on Wednesday, January 3rd. The stock was sold at an average price of $480.00, for a total value of $6,732,480.00. Following the completion of the sale, the chief executive officer now owns 43,445 shares in the company, valued at $20,853,600. The sale was disclosed in a legal filing with the SEC, which is available at this link. 0.21% of the stock is currently owned by insiders.

McKesson Stock Up 0.7 %

MCK stock opened at $508.12 on Tuesday. The company has a 50-day simple moving average of $471.79 and a 200 day simple moving average of $449.19. The company has a market capitalization of $67.61 billion, a P/E ratio of 20.08, a PEG ratio of 1.77 and a beta of 0.44. McKesson Co. has a fifty-two week low of $331.75 and a fifty-two week high of $510.94.

McKesson Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Monday, April 1st. Investors of record on Friday, March 1st will be issued a dividend of $0.62 per share. The ex-dividend date of this dividend is Thursday, February 29th. This represents a $2.48 annualized dividend and a yield of 0.49%. McKesson’s payout ratio is 9.80%.

McKesson Company Profile

(Free Report)

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.

Featured Stories

Want to see what other hedge funds are holding MCK? Visit to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCKFree Report).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with's FREE daily email newsletter.